lobbying_activities: 1668224

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1668224	e66e36e6-55f8-4f80-aa77-1080097adaa5	Q1	BROWN RUDNICK LLP	287895	AMNEAL PHARMACEUTICALS	2015	first_quarter	PHA	Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); Issues relating to ANDA review and approval	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2015-04-17T14:40:21.757000-04:00